NVST
Price
$25.55
Change
-$0.32 (-1.24%)
Updated
Sep 11 closing price
Capitalization
4.1B
53 days until earnings call
Intraday BUY SELL Signals
VREX
Price
$18.46
Change
-$0.01 (-0.05%)
Updated
Sep 11 closing price
Capitalization
778.06M
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVST vs VREX

NVST vs VREX Comparison Chart in %
View a ticker or compare two or three
VS
NVST vs. VREX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and VREX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($4.1B) has a higher market cap than VREX($778M). NVST has higher P/E ratio than VREX: NVST (44.05) vs VREX (34.83). VREX YTD gains are higher at: 58.455 vs. NVST (17.688). NVST has higher annual earnings (EBITDA): 421M vs. VREX (83M). NVST has more cash in the bank: 1.13B vs. VREX (99.2M). VREX has less debt than NVST: VREX (374M) vs NVST (1.59B). NVST has higher revenues than VREX: NVST (2.86B) vs VREX (865M).
NVSTVREXNVST / VREX
Capitalization4.1B778M528%
EBITDA421M83M507%
Gain YTD17.68858.45530%
P/E Ratio44.0534.83126%
Revenue2.86B865M330%
Total Cash1.13B99.2M1,135%
Total Debt1.59B374M425%
FUNDAMENTALS RATINGS
NVST vs VREX: Fundamental Ratings
NVST
VREX
OUTLOOK RATING
1..100
6178
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8784
PRICE GROWTH RATING
1..100
5236
P/E GROWTH RATING
1..100
8340
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (56) in the null industry is somewhat better than the same rating for VREX (89) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than VREX’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as VREX (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to VREX’s over the last 12 months.

VREX's SMR Rating (84) in the Medical Specialties industry is in the same range as NVST (87) in the null industry. This means that VREX’s stock grew similarly to NVST’s over the last 12 months.

VREX's Price Growth Rating (36) in the Medical Specialties industry is in the same range as NVST (52) in the null industry. This means that VREX’s stock grew similarly to NVST’s over the last 12 months.

VREX's P/E Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for NVST (83) in the null industry. This means that VREX’s stock grew somewhat faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTVREX
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 10 days ago
66%
Bullish Trend 16 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
45%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (NVST: $25.55 vs. VREX: $18.46)
Brand notoriety: NVST and VREX are both not notable
NVST represents the Pharmaceuticals: Other, while VREX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NVST: 147% vs. VREX: 120%
Market capitalization -- NVST: $4.1B vs. VREX: $778.06M
NVST [@Pharmaceuticals: Other] is valued at $4.1B. VREX’s [@Medical/Nursing Services] market capitalization is $778.06M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green while VREX’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, VREX is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 4 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 6 bearish.
  • VREX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VREX is a better buy in the short-term than NVST.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а -6.34% price change this week, while VREX (@Medical/Nursing Services) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

NVST is expected to report earnings on Nov 04, 2026.

VREX is expected to report earnings on Nov 24, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NVST
Daily Signal:
Gain/Loss:
VREX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWTCX16.98N/A
N/A
Virtus Duff & Phelps Water C
BINSX15.10N/A
N/A
Baillie Gifford International Alpha I
VBINX54.22N/A
N/A
Vanguard Balanced Index Inv
BIAWX48.10N/A
N/A
Brown Advisory Sustainable Growth Inv
SGAPX20.06N/A
N/A
Virtus SGA Global Growth I

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with XRAY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-1.24%
XRAY - NVST
60%
Loosely correlated
-0.38%
ALGN - NVST
58%
Loosely correlated
+0.07%
BIO - NVST
57%
Loosely correlated
+0.15%
A - NVST
55%
Loosely correlated
+2.66%
MTD - NVST
52%
Loosely correlated
+1.01%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.05%
NVST - VREX
51%
Loosely correlated
-1.24%
ATR - VREX
47%
Loosely correlated
+1.45%
A - VREX
47%
Loosely correlated
+2.66%
ISRG - VREX
43%
Loosely correlated
+2.41%
DHR - VREX
43%
Loosely correlated
-0.19%
More